Dong-Ku Kang,
Assistant Research Scientist
Dr. Dong-Ku Kang is a Research Scientist of Biomedical engineering at University of California Irvine and he was a Newton Research Fellow at Imperial College London before joining UC-Irvine. Dr. Kang is also the Co-founder of Velox Biosystems, a start-up company that aims to develop rapid and sensitive diagnostic technologies. He has co-authored > 40 journal articles in highly respected journals including Nature Communications, Chemical Communications, Analytical Chemistry and Lab On A Chip. Dr. Kang has received numerous awards including the prestigious Newton Research Award (2009, the world’s top 50 young investigators, Royal Society, UK) and Tony B. Academic Award (SLAS, USA). His current research aim is the development of miniaturized devices for diagnosis and monitoring of various diseases including cancer, neurological disorder, and infectious diseases. More specifically, his research is dedicated to develop single molecule (or cell) digital detection for the absolute quantification of rare biomarkers in the complex biological samples such as blood and plasma using nano/micro technologies.
|
|
|
